Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
CN104546680A - Aspirin composition freeze-dried tablets and preparation method thereof - Google Patents
[go: Go Back, main page]

CN104546680A - Aspirin composition freeze-dried tablets and preparation method thereof - Google Patents

Aspirin composition freeze-dried tablets and preparation method thereof Download PDF

Info

Publication number
CN104546680A
CN104546680A CN201410829255.9A CN201410829255A CN104546680A CN 104546680 A CN104546680 A CN 104546680A CN 201410829255 A CN201410829255 A CN 201410829255A CN 104546680 A CN104546680 A CN 104546680A
Authority
CN
China
Prior art keywords
aspirin
tablets
solution
hours
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410829255.9A
Other languages
Chinese (zh)
Inventor
柳清华
李彪
石金友
汪金灿
郝结兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Original Assignee
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Weikang Pharmaceutical Qianshan Co Ltd filed Critical Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority to CN201410829255.9A priority Critical patent/CN104546680A/en
Publication of CN104546680A publication Critical patent/CN104546680A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides aspirin composition freeze-dried tablets and a preparation method thereof, and relates to the technical field of medicine and medicine production. The aspirin composition freeze-dried tablets comprise aspirin, starch and sucrose, wherein starch and sucrose are used as accessories. Ordinary corn starch is treated by a heating process, so that the bonding and disintegration effects of starch in the tablets can be improved, and the forming property of the tablets can be improved; only starch and sucrose are required to be used as the accessories of the aspirin composition freeze-dried tablets. A two-cooling two-heating freeze-drying process is adopted for the aspirin composition freeze-dried tablets, and by twice cooling and twice heating, better forming property of the tablets can be achieved, and the dissolubility of the tablets is improved, so that the bioavailability of the tablets is improved. According to the tablets, the defects of ordinary aspirin tablets are overcome, the sort and using amounts of the accessories in the aspirin tablets are reduced, the tablets are high in dissolubility and bioavailability, and the curative effects and safety of clinical mediation are ensured.

Description

A kind of aspirin composition lyophilizing sheet and preparation method thereof
Technical field
The present invention relates to medicine and medical production technical field, be specifically related to a kind of aspirin composition lyophilizing sheet and preparation method thereof.
Background technology
Aspirin is a kind of time-honored antipyretic analgesic.For curing cold, generating heat, have a headache, have a toothache, arthralgia, rheumatism, can also anticoagulant, for prevention and therapy ischemic heart desease, angina pectoris, cardiopulmonary infraction, cerebral thrombosis, be applied to revascularization and bypass graft is also effective
structural formula
Molecular weight: 180.16
In common aspirin tablet containing supplementary product kind and quantity more, generally to use filler, lubricant, disintegrating agent, adhesive, correctives etc., according to Chinese Pharmacopoeia (2010 editions) second aspirin tablet quality standard, the dissolution of aspirin tablet reached more than 80% for qualified 30 minutes time, and increasing research shows that impurity in the incompatibility of the toxic and side effects of adjuvant itself, adjuvant and principal agent, adjuvant etc. all can have an impact to the safety of medicine.
Therefore, provide one can overcome above-mentioned shortcoming, select suitable adjuvant and technique, reduce supplementary product kind and consumption in aspirin tablet, improve dissolution and the bioavailability of aspirin tablet, ensure that the safety of clinical application all has positive effect.
Traditional lyophilizing tablet can improve dissolution and bioavailability, but still need use the adjuvant such as mannitol, gelatin.And mannitol has certain biological activity, gelatin resource-constrained and perishable.
Starch is the basic adjuvant of oral solid formulation, it is polymerized by glucose molecule, and be commonly used for adhesive, diluent and disintegrating agent in tablets, it is cheap and easy to get, to human-body safety, but being used alone starch has no report as adjuvant freeze-dry process production aspirin lyophilizing sheet.
Summary of the invention
Technical problem to be solved by this invention is the defect overcoming prior art, and propose a kind of aspirin composition lyophilizing sheet and preparation method thereof further, said preparation adjuvant is few, good stability, and bioavailability is high.
Technical problem to be solved by this invention realizes by the following technical solutions:
A kind of aspirin composition lyophilizing sheet, adjuvant is done with starch and sucrose, produce with freeze-dry process, this tablet overcomes the shortcoming of above-mentioned common aspirin tablet, decrease supplementary product kind and consumption in aspirin tablet, this sheet dissolution is large, and bioavailability is high, ensure that curative effect and the safety of clinical application.
A kind of aspirin composition lyophilizing sheet, is prepared from by following raw material:
A preparation method for aspirin composition lyophilizing sheet, comprises step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100ml, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take aspirin 50 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring aspirin content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain aspirin composition lyophilizing sheet.
Described starch selects corn starch, preferably the corn starch solution of 10% (W/V).
Beneficial effect of the present invention is:
The preparation method of a kind of aspirin composition lyophilizing sheet of the present invention, heating process process is carried out to common corn starch, starch bonding in tablets, disintegration can be improved, improve the mouldability of tablet, in aspirin composition lyophilizing sheet, dosage of sucrose is 8.5% (W/V), it is the hardness reinforcer of this tablet, and plays flavored action.Aspirin composition lyophilizing sheet only needs starch and sucrose two kinds of adjuvants.The freeze-dry process of two liters falls in aspirin composition lyophilizing sheet employing two, and twice cooling, twice intensification can make sheet mouldability better, which increase the dissolution of tablet, thus improve the bioavailability of tablet.
Accompanying drawing explanation
Fig. 1 is the dissolution correlation curve figure of aspirin in experiment.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, set forth the present invention further, but following embodiment being only the preferred embodiments of the present invention, and not all.Based on the embodiment in embodiment, those skilled in the art under the prerequisite not making creative work obtain other embodiment, all belong to the protection domain of this patent.
Embodiment 1
A, take the corn starch of 100g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 9% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take aspirin 50g, add in 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring aspirin content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain aspirin composition lyophilizing sheet.
Embodiment 2
A, take the corn starch of 130g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 13% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take aspirin 50 grams (by 1000 calculations), add 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring aspirin content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain aspirin composition lyophilizing sheet.
Experimental data
The aspirin composition lyophilizing sheet that above-described embodiment is obtained carries out following quality research test:
1, hardness, friability contrast test
Get aspirin composition lyophilizing sheet prepared by above-described embodiment respectively and aspirin ordinary tablet (commercially available) detects friability and hardness by " Chinese Pharmacopoeia " version in 2010 two annex X G inspection techniques, carried out comparative study, the results are shown in following table:
Sample Hardness/N Friability
Execute example 1 63 <1%
Execute example 2 64 <1%
Ordinary tablet 63 <1%
Experimental data shows, aspirin composition lyophilizing sheet and ordinary tablet (commercially available) without significant difference, meet " Chinese Pharmacopoeia " version in 2010 to the requirement of tablet on friability and hardness.
2, dissolution contrast test
(No. 1 to No. 3 is embodiment 1 to get aspirin tablet (commercially available) and each 6 of aspirin composition lyophilizing sheet, No. 4 to No. 6 is embodiment 2), press Chinese Pharmacopoeia (2010 editions) second dissolution method annex X C first method respectively, with hydrochloric acid solution, (dilute hydrochloric acid 24ml adds water to 1000ml, obtaining) 500ml is dissolution medium, rotating speed is 100 turns per minute, operate in accordance with the law, respectively when 10min, 20min, 30min, 40min, get solution 10ml to filter, get continuous worry liquid as test sample; Separately get aspirin reference substance, accurately weighed, add the dissolve with methanol solution of 1% glacial acetic acid and be diluted to the solution containing 0.08mg in every 1ml, as aspirin reference substance solution; Get salicylic acid reference substance, accurately weighed, add the dissolve with methanol solution of 1% glacial acetic acid and be diluted to the solution containing 0.01mg in every 1ml, as salicylic acid reference substance solution.According to chromatographic condition under assay item, precision measures need testing solution, aspirin reference substance liquid and each 10ul of salicylic acid reference substance solution, respectively injection liquid chromatography, record chromatogram.Calculate often aspirin and salicylic content in group according to external standard method respectively with peak area, after salicylic content is multiplied by 1.304, is added with aspirin content and obtains stripping quantity.Be measured in the same method, calculate the stripping quantity of every sheet.Result is as follows:
One, aspirin tablet (commercially available)
Two, aspirin lyophilizing sheet (No. 1 to No. 3 is embodiment 1, and No. 4 to No. 6 is embodiment 2)
Respectively with catch cropping Dissolution profiles during average dissolution pair, as Fig. 1.
Four, result judges
Judge according to Chinese Pharmacopoeia (2010 editions) second aspirin tablet quality standard, the dissolution of aspirin tablet (commercially available) reached more than 80% for qualified 30 minutes time, actual measurement is 84.4%, and aspirin lyophilizing sheet dissolution 20 minutes time reaches 84.6%.It can thus be appreciated that the time that aspirin lyophilizing sheet dissolution reaches 80% decreased for about 33.3% (10 minutes) time than aspirin tablet (commercially available).So the aspirin lyophilizing sheet blood drug level peaking time is shorter than aspirin tablet (commercially available), and bioavailability is higher, better efficacy.
More than show and describe ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.

Claims (2)

1. an aspirin composition lyophilizing sheet, is characterized in that, is prepared from by following raw material:
2. a preparation method for aspirin composition lyophilizing sheet according to claim 1, is characterized in that, comprise step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100ml, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take aspirin 50 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring aspirin content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain aspirin composition lyophilizing sheet.
CN201410829255.9A 2014-12-25 2014-12-25 Aspirin composition freeze-dried tablets and preparation method thereof Pending CN104546680A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410829255.9A CN104546680A (en) 2014-12-25 2014-12-25 Aspirin composition freeze-dried tablets and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410829255.9A CN104546680A (en) 2014-12-25 2014-12-25 Aspirin composition freeze-dried tablets and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104546680A true CN104546680A (en) 2015-04-29

Family

ID=53064466

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410829255.9A Pending CN104546680A (en) 2014-12-25 2014-12-25 Aspirin composition freeze-dried tablets and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104546680A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018222583A1 (en) * 2017-05-30 2018-12-06 Rho Pharmaceuticals, Llc In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use
CN103877034A (en) * 2012-12-19 2014-06-25 青岛康地恩药业股份有限公司 Aspirin tablet and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use
CN103877034A (en) * 2012-12-19 2014-06-25 青岛康地恩药业股份有限公司 Aspirin tablet and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘晓睿: "《口腔速溶片的研究进展》", 《中南药学》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018222583A1 (en) * 2017-05-30 2018-12-06 Rho Pharmaceuticals, Llc In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
US10959955B1 (en) 2017-05-30 2021-03-30 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
US11096949B2 (en) 2017-05-30 2021-08-24 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid
US11911400B1 (en) 2017-05-30 2024-02-27 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid (aspirin)
US12048708B2 (en) 2017-05-30 2024-07-30 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

Similar Documents

Publication Publication Date Title
CN104490828A (en) Dexamethasone composition freeze-dried tablet and preparation method thereof
CN104546749A (en) Lorazepam composition freeze-dried tablet and preparation method thereof
CN104546680A (en) Aspirin composition freeze-dried tablets and preparation method thereof
CN104490750A (en) Spirolactone composition freeze-dried tablets and preparation method thereof
CN104546678A (en) Aspirin composition freeze-dried tablets and preparation method thereof
CN104490752A (en) Tranexamic acid composition lyophilized tablet and preparation method thereof
CN104523629A (en) Lisinopril composition freeze-dried tablets and preparation method thereof
CN104490831A (en) Ferrous sulfate composition freeze-dried tablets and preparation method thereof
CN104490832A (en) Lyophilized tablet prepared from warfarin composition and preparation method thereof
CN104586785A (en) Nilestriol composition freeze-dried tablets and preparation method thereof
CN104586749A (en) Metronidazole composition freeze-dried tablet and preparation method thereof
CN104490830A (en) Bezafibrate composition freeze-dried tablet and preparation method thereof
CN104490756A (en) Isosorbide mononitrate composition freeze-dried tablet and preparation method thereof
CN104546859A (en) Dimenhydrinate composition freeze-dried tablets and preparation method thereof
CN104546683A (en) Carbocisteine composition freeze-drying tablet and preparation method thereof
CN104490754A (en) Lyophilized tablet prepared from captopril composition and preparation method thereof
CN104546679A (en) Ibuprofen composition freeze-dried tablets and preparation method thereof
CN104490751A (en) Hydrochlorothiazide composition freeze-dried tablets and preparation method thereof
CN104434833A (en) Melbine composition freeze-dried tablet and preparation method thereof
CN104606156A (en) Diethylstilbestrol composition lyophilized tablet and preparation method thereof
CN104490824A (en) Felodipine composition freeze-dried tablet and preparation method thereof
CN104546761A (en) Acetaminophen composition freezing-drying tablet and preparation method thereof
CN104434831A (en) Glipizide composition freeze-dried tablet and preparation method thereof
CN104546752A (en) Dipyridamole composition freeze-drying tablet and preparation method thereof
CN104490758A (en) Leflunomide composition freeze-dried tablets and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150429